95 related articles for article (PubMed ID: 10993229)
1. Direct identification of a novel disulfide bond linkage system of new isolated isomer (isomer V) in recombinantly produced h-IGF-I.
Iwai M; Yokoyama H; Yamada H; Niwa M; Kobayashi M
Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1304-9. PubMed ID: 10993229
[TBL] [Abstract][Full Text] [Related]
2. Probing the disulfide folding pathway of insulin-like growth factor-I.
Milner SJ; Carver JA; Ballard FJ; Francis GL
Biotechnol Bioeng; 1999 Mar; 62(6):693-703. PubMed ID: 9951525
[TBL] [Abstract][Full Text] [Related]
3. Direct identification of disulfide bond linkages in human insulin-like growth factor I (IGF-I) by chemical synthesis.
Iwai M; Kobayashi M; Tamura K; Ishii Y; Yamada H; Niwa M
J Biochem; 1989 Dec; 106(6):949-51. PubMed ID: 2628430
[TBL] [Abstract][Full Text] [Related]
4. Disulfide arrangement of human insulin-like growth factor I derived from yeast and plasma.
Axelsson K; Johansson S; Eketorp G; Zazzi H; Hemmendorf B; Gellerfors P
Eur J Biochem; 1992 Jun; 206(3):987-94. PubMed ID: 1606975
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional solution structure of a disulfide bond isomer of the human insulin-like growth factor-I.
Sato A; Koyama S; Yamada H; Suzuki S; Tamura K; Kobayashi M; Niwa M; Yasuda T; Kyogoku Y; Kobayashi Y
J Pept Res; 2000 Oct; 56(4):218-30. PubMed ID: 11083061
[TBL] [Abstract][Full Text] [Related]
6. Binding protein, radioreceptor and biological activities of recombinant methionyl insulin-like growth factor-I variants.
Hodgkinson SC; Napier JR; Davis SR; Patel B; Gluckman PD
Mol Cell Endocrinol; 1989 Sep; 66(1):37-44. PubMed ID: 2479583
[TBL] [Abstract][Full Text] [Related]
7. Development of an optimized refolding process for recombinant Ala-Glu-IGF-1.
Hejnaes KR; Bayne S; Nørskov L; Sørensen HH; Thomsen J; Schäffer L; Wollmer A; Skriver L
Protein Eng; 1992 Dec; 5(8):797-806. PubMed ID: 1287661
[TBL] [Abstract][Full Text] [Related]
8. Refolding of amphioxus insulin-like peptide: implications of a bifurcating evolution of the different folding behavior of insulin and insulin-like growth factor 1.
Wang S; Guo ZY; Shen L; Zhang YJ; Feng YM
Biochemistry; 2003 Aug; 42(32):9687-93. PubMed ID: 12911310
[TBL] [Abstract][Full Text] [Related]
9. Putative folding pathway of insulin-like growth factor-I.
Rosenfeld RD; Miller JA; Narhi LO; Hawkins N; Katta V; Lauren S; Weiss MA; Arakawa T
Arch Biochem Biophys; 1997 Jun; 342(2):298-305. PubMed ID: 9186491
[TBL] [Abstract][Full Text] [Related]
10. Structure and activity dependence of recombinant human insulin-like growth factor II on disulfide bond pairing.
Smith MC; Cook JA; Furman TC; Occolowitz JL
J Biol Chem; 1989 Jun; 264(16):9314-21. PubMed ID: 2722836
[TBL] [Abstract][Full Text] [Related]
11. 1.42A crystal structure of mini-IGF-1(2): an analysis of the disulfide isomerization property and receptor binding property of IGF-1 based on the three-dimensional structure.
Yun CH; Tang YH; Feng YM; An XM; Chang WR; Liang DC
Biochem Biophys Res Commun; 2005 Jan; 326(1):52-9. PubMed ID: 15567151
[TBL] [Abstract][Full Text] [Related]
12. Oxidative refolding of insulin-like growth factor 1 yields two products of similar thermodynamic stability: a bifurcating protein-folding pathway.
Miller JA; Narhi LO; Hua QX; Rosenfeld R; Arakawa T; Rohde M; Prestrelski S; Lauren S; Stoney KS; Tsai L
Biochemistry; 1993 May; 32(19):5203-13. PubMed ID: 8494897
[TBL] [Abstract][Full Text] [Related]
13. The different energetic state of the intra A-chain/domain disulfide of insulin and insulin-like growth factor 1 is mainly controlled by their B-chain/domain.
Guo ZY; Shen L; Feng YM
Biochemistry; 2002 Aug; 41(34):10585-92. PubMed ID: 12186542
[TBL] [Abstract][Full Text] [Related]
14. Sequences of B-chain/domain 1-10/1-9 of insulin and insulin-like growth factor 1 determine their different folding behavior.
Chen Y; You Y; Jin R; Guo ZY; Feng YM
Biochemistry; 2004 Jul; 43(28):9225-33. PubMed ID: 15248780
[TBL] [Abstract][Full Text] [Related]
15. The different folding behavior of insulin and insulin-like growth factor 1 is mainly controlled by their B-chain/domain.
Guo ZY; Shen L; Feng YM
Biochemistry; 2002 Feb; 41(5):1556-67. PubMed ID: 11814349
[TBL] [Abstract][Full Text] [Related]
16. Putative disulfide-forming pathway of porcine insulin precursor during its refolding in vitro.
Qiao ZS; Guo ZY; Feng YM
Biochemistry; 2001 Mar; 40(9):2662-8. PubMed ID: 11258877
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the B-domain of insulin-like growth factor-I influence the oxidative folding to yield products with modified biological properties.
Milner SJ; Francis GL; Wallace JC; Magee BA; Ballard FJ
Biochem J; 1995 Jun; 308 ( Pt 3)(Pt 3):865-71. PubMed ID: 8948444
[TBL] [Abstract][Full Text] [Related]
18. Diversity of human insulin-like growth factor (IGF) binding protein-2 fragments in plasma: primary structure, IGF-binding properties, and disulfide bonding pattern.
Mark S; Kübler B; Höning S; Oesterreicher S; John H; Braulke T; Forssmann WG; Ständker L
Biochemistry; 2005 Mar; 44(9):3644-52. PubMed ID: 15736974
[TBL] [Abstract][Full Text] [Related]
19. Disulfide exchange folding of insulin-like growth factor I.
Hober S; Forsberg G; Palm G; Hartmanis M; Nilsson B
Biochemistry; 1992 Feb; 31(6):1749-56. PubMed ID: 1737028
[TBL] [Abstract][Full Text] [Related]
20. Thrombin-binding affinities of different disulfide-bonded isomers of the fifth EGF-like domain of thrombomodulin.
Hunter MJ; Komives EA
Protein Sci; 1995 Oct; 4(10):2129-37. PubMed ID: 8535250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
